We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$450M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow %
100.52%
Top 10 Hldgs %
30.22%
Holding
133
New
133
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$16.2M
2
KSU
Kansas City Southern
KSU
+$15.7M
3
PARA
Paramount Global Class B
PARA
+$14.3M
4
MCO icon
Moody's
MCO
+$13.6M
5
CYH icon
Community Health Systems
CYH
+$13.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 19.03%
2 Industrials 15.7%
3 Healthcare 14.53%
4 Consumer Discretionary 10.01%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSI
126
DELISTED
LSI CORPORATION
LSI
$1K ﹤0.01%
+116
New +$794
AAPL icon
127
Apple
AAPL
$4.56T
$0 ﹤0.01%
+28
New +$431
AGCO icon
128
AGCO
AGCO
$7.12B
$0 ﹤0.01%
+1
New +$53
AFSI
129
DELISTED
AmTrust Financial Services, Inc.
AFSI
$0 ﹤0.01%
+9
New +$136
TSCC
130
DELISTED
TECHNOLOGY SOLUTIONS CO NEW
TSCC
$0 ﹤0.01%
+75
New –
2 3 4 5
6

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
KJWM
Kiley Juergens Wealth Management Olympia, Washington $567M AUM 27.42% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return

Contravisory Investment Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Contravisory Investment Management, which disclosed 133 positions worth $450M. Its ten largest holdings account for 30% of the portfolio.

Its largest position is Gilead Sciences: 310,026 shares worth $15.9M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Industrials and Healthcare.

  • Contravisory Investment Management's largest Q2 2013 buy was Gilead Sciences: 310,026 shares worth $15.9M.
  • Contravisory Investment Management's ten largest holdings make up 30% of its $450M portfolio in Q2 2013.
  • Contravisory Investment Management disclosed 133 positions in Q2 2013, its first 13F filing on record.

Based on Contravisory Investment Management's 13F filing for Q2 2013, filed 15 Jul 2013.